Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Change in Cash (2021 - 2025)

Historic Change in Cash for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to $2.9 million.

  • Coeptis Therapeutics Holdings' Change in Cash rose 79722.24% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 147599.89%. This contributed to the annual value of -$936249.0 for FY2024, which is 5968.21% up from last year.
  • Coeptis Therapeutics Holdings' Change in Cash amounted to $2.9 million in Q3 2025, which was up 79722.24% from -$2.3 million recorded in Q2 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Change in Cash registered a high of $5.0 million during Q3 2022, and its lowest value of -$3.6 million during Q4 2022.
  • Moreover, its 5-year median value for Change in Cash was -$59847.0 (2021), whereas its average is $247659.1.
  • Per our database at Business Quant, Coeptis Therapeutics Holdings' Change in Cash surged by 844229.79% in 2022 and then plummeted by 114915.83% in 2024.
  • Quarter analysis of 5 years shows Coeptis Therapeutics Holdings' Change in Cash stood at $2.3 million in 2021, then crashed by 255.69% to -$3.6 million in 2022, then soared by 101.61% to $57624.0 in 2023, then plummeted by 1149.16% to -$604567.0 in 2024, then surged by 581.63% to $2.9 million in 2025.
  • Its Change in Cash was $2.9 million in Q3 2025, compared to -$2.3 million in Q2 2025 and $3.7 million in Q1 2025.